Bayer Crop Science Intrinsic Value
BAYERCROP Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1626.00 | ₹1300.80 - ₹1951.20 | -63.8% | EPS: ₹135.50, Sector P/E: 12x |
| Book Value Method | asset | ₹899.14 | ₹809.23 - ₹989.05 | -80.0% | Book Value/Share: ₹633.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1348.71 | ₹1213.84 - ₹1483.58 | -70.0% | Revenue/Share: ₹1260.89, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1798.28 | ₹1618.45 - ₹1978.11 | -60.0% | EBITDA: ₹847.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1798.28 | ₹1438.62 - ₹2157.94 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1348.71 | ₹1213.84 - ₹1483.58 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1348.71 | ₹1213.84 - ₹1483.58 | -70.0% | Revenue Growth: 4.3%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹2247.85 | ₹2023.07 - ₹2472.64 | -50.0% | ROE: 21.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1348.71 | ₹1213.84 - ₹1483.58 | -70.0% | EPS: ₹135.50, BVPS: ₹633.33 |
Want to compare with current market value? Check BAYERCROP share price latest .
Valuation Comparison Chart
BAYERCROP Intrinsic Value Analysis
What is the intrinsic value of BAYERCROP?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Bayer Crop Science (BAYERCROP) is ₹1348.71 (median value). With the current market price of ₹4495.70, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹899.14 to ₹2247.85, indicating ₹899.14 - ₹2247.85.
Is BAYERCROP undervalued or overvalued?
Based on our multi-method analysis, Bayer Crop Science (BAYERCROP) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 26.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.84 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 21.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 12.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.08x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Bayer Crop Science
Additional stock information and data for BAYERCROP
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹262 Cr | ₹262 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹952 Cr | ₹952 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹609 Cr | ₹609 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹216 Cr | ₹216 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹687 Cr | ₹687 Cr | Positive Free Cash Flow | 8/10 |